Androstanolone

雄诺龙

Report date: 2026/02/28 09:40:15
NME

Base Information

Drug NameAndrostanolone
Drug Alias Name双氢睾酮Dihydrotestosterone雄烯醇酮Testosterone gelandrostanolonum +[11] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsHypogonadismLichen Sclerosus et AtrophicusGynecomastia +[5] 
Global Approved IndicationsHypogonadismLichen Sclerosus et AtrophicusGynecomastia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date1981/01/23
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBesins Healthcare
Inactive CompaniesAscend TherapeuticsWake Forest University Health SciencesUniversity Of Washington
Active IndicationsHypogonadismLichen Sclerosus et AtrophicusGynecomastia
Inactive IndicationsSpinocerebellar DegenerationsProstatic Neoplasms

Other Information

ATC CodeA14AA01G03BB02
Related LinksWikipediaDrugBankKEGG